NV

Neil Verdal-Austin

Mr Verdal-Austin has acted as Chief Executive Officer of the Company since November 2018. He is a experienced, and business focused individual, having worked for medical device companies in South Africa, the UK and in Australia for over 25 years. He has a proven track record in various roles in SomnoMed, with many years of deep involvement in our businesses in Europe, the US and Asia-Pacific.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
SOM
SOM
22/02/24160,0001,591,050910,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
SOM
SOM
22/02/24
Transfer
160,000$0.400$64,000Off-market transfer
SOM
SOM
22/02/24
Transfer
160,000$0.400$64,000Off-market transfer
SOM
SOM
28/09/23
Issued
41,650$0.600$24,990Rights issue
SOM
SOM
18/03/22
Sell
49,383$1.647$81,337On-market trade
SOM
SOM
06/08/21
Issued
910,000$0.154$140,140Issue of securities